Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series

Overview of attention for article published in Drugs & Therapy Perspectives, March 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 11,357 followers.

RT @TerraPharma1: 1a. Switching from lovaza to Vascepa $AMRN https://t.co/JpJh1jz5nN 1b.. Case study https://t.co/emMHiRIVJ3 2. Switching…

1a. Switching from lovaza to Vascepa $AMRN https://t.co/JpJh1jz5nN 1b.. Case study https://t.co/emMHiRIVJ3 2. Switching from fenofibrates to Vascepa https://t.co/rdWzclaclQ

RT @greenday_bio: Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: https://t.co/J6j…

Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: https://t.co/J6jlP3tqr3 $AMRN

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.